Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05494073 · ClinicalTrials.gov registry record · NA
Anterior Cruciate Ligament Reconstruction Hybrid Remnant Repair
A NA study of Anterior Cruciate Ligament Tear, sponsored by Henry Ford Health System.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05494073 is a NA study of Anterior Cruciate Ligament Tear that is active but no longer recruiting, run by Henry Ford Health System. The registered enrollment target is 100 participants, below the 221-participant average among 11 other Anterior Cruciate Ligament Tear trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05494073, a NA study of Anterior Cruciate Ligament Tear, is active but no longer recruiting, sponsored by Henry Ford Health System.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients between 14-60 years of age who will undergo an anterior cruciate ligament (ACL) reconstruction between Nov 1, 2021- Dec 31, 2023, will have their charts reviewed be approached in clinic when the surgery is scheduled regarding their participation in this study. At the time of consent, patients will be randomized to a group via a computerized randomization process, either the experimental hybrid remnant repair (HRR) or traditional ACL reconstruction with ACL stump debridement. Routine postoperative data will be collected at regularly scheduled post-operative and physical therapy appointments including range of motion, pain, patient-reported outcomes, return-to-sport tests, and proprioceptive data. Additionally, patients will be asked to undergo a post-operative MRI between 9 and 15 months following the date of their surgery. Radiologists reading the MRIs will be blinded to which group the patient is in. The primary outcome measure is graft incorporation between the two groups.
Conditions Studied
Interventions
- PROCEDURE ACL Reconstruction with Hybrid Remnant Repair
- PROCEDURE ACL Reconstruction without Hybrid Remnant Repair
Study Locations (1)
Michigan
- Henry Ford Hospital - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-12-13 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05494073
The ClinicalTrials.gov registry entry for NCT05494073 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 11 other Anterior Cruciate Ligament Tear trials with a reported enrollment target (55% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anterior Cruciate Ligament Tear appearing as the primary indexed condition, and to 2 interventions - of which ACL Reconstruction with Hybrid Remnant Repair is the first listed.
NCT05494073 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05494073 about?
NCT05494073 is a clinical study titled "Anterior Cruciate Ligament Reconstruction Hybrid Remnant Repair". Patients between 14-60 years of age who will undergo an anterior cruciate ligament (ACL) reconstruction between Nov 1, 2021- Dec 31, 2023, will have their charts reviewed be approached in clinic when the surgery is scheduled regarding their participation in this study. At the time of consent, patien...
What is the current status of trial NCT05494073?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2021-12-13. Estimated completion is 2026-11.
What conditions does trial NCT05494073 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Tear.
What interventions are being tested in trial NCT05494073?
The interventions under investigation include: ACL Reconstruction with Hybrid Remnant Repair (PROCEDURE), ACL Reconstruction without Hybrid Remnant Repair (PROCEDURE).
Who is sponsoring clinical trial NCT05494073?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05494073 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bridge-Enhanced ACL Repair-Safety Study (BEAR Trial)
ACTIVE NOT RECRUITING · NA
-
Bridge-Enhanced ACL Repair vs ACL Reconstruction
ACTIVE NOT RECRUITING · NA
-
Tendon-Bone Versus All-Soft-Tissue for ACL Reconstruction: A Patient-Blinded Randomized Clinical Trial
ACTIVE NOT RECRUITING · NA
-
A Comparison of ACL Repair With BEAR Device vs. Autograft Patellar Tendon ACL Reconstruction
ACTIVE NOT RECRUITING · NA
-
Utilization of a 3D Printed Customized Knee Extender and At-Home Rehabilitation Program on Patient Outcomes Following ACL Surgery
ACTIVE NOT RECRUITING · NA
-
Regenexx™ SD Versus Exercise Therapy for ACL Tears
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.